Lal A - Search Results

1

Hemoglobin Hakkari: an autosomal dominant form of beta thalassemia with inclusion bodies arising from de novo mutation in exon 2 of beta globin gene.

Kanathezhath B, Hazard FK, Guo H, Kidd J, Azimi M, Kuypers FA, Vichinsky EP, Lal A. Kanathezhath B, et al. Among authors: lal a. Pediatr Blood Cancer. 2010 Feb;54(2):332-5. doi: 10.1002/pbc.22167. Pediatr Blood Cancer. 2010. PMID: 19852066

2

The role of fetal hemoglobin-enhancing agents in thalassemia.

Lal A, Vichinsky E. Lal A, et al. Semin Hematol. 2004 Oct;41(4 Suppl 6):17-22. doi: 10.1053/j.seminhematol.2004.08.004. Semin Hematol. 2004. PMID: 15534853 Review.

3

Bone mineral density in children with sickle cell anemia.

Lal A, Fung EB, Pakbaz Z, Hackney-Stephens E, Vichinsky EP. Lal A, et al. Pediatr Blood Cancer. 2006 Dec;47(7):901-6. doi: 10.1002/pbc.20681. Pediatr Blood Cancer. 2006. PMID: 16317761

4

Measuring chromosome breaks in patients with thalassemia.

Offer T, Bhagat A, Lal A, Atamna W, Singer ST, Vichinsky EP, Kuypers FA, Ames BN. Offer T, et al. Among authors: lal a. Ann N Y Acad Sci. 2005;1054:439-44. doi: 10.1196/annals.1345.050. Ann N Y Acad Sci. 2005. PMID: 16339694

5

Heterogeneity of hemoglobin H disease in childhood.

Lal A, Goldrich ML, Haines DA, Azimi M, Singer ST, Vichinsky EP. Lal A, et al. N Engl J Med. 2011 Feb 24;364(8):710-8. doi: 10.1056/NEJMoa1010174. N Engl J Med. 2011. PMID: 21345100 Free article.

6

Combined chelation therapy with deferasirox and deferoxamine in thalassemia.

Lal A, Porter J, Sweeters N, Ng V, Evans P, Neumayr L, Kurio G, Harmatz P, Vichinsky E. Lal A, et al. Blood Cells Mol Dis. 2013 Feb;50(2):99-104. doi: 10.1016/j.bcmd.2012.10.006. Epub 2012 Nov 11. Blood Cells Mol Dis. 2013. PMID: 23151373 Free PMC article. Clinical Trial.

7

Point-of-care end-tidal carbon monoxide reflects severity of hemolysis in sickle cell anemia.

Lal A, Patterson L, Goldrich A, Marsh A. Lal A, et al. Pediatr Blood Cancer. 2015 May;62(5):912-4. doi: 10.1002/pbc.25447. Epub 2015 Feb 14. Pediatr Blood Cancer. 2015. PMID: 25683629 Free PMC article.

8

Favorable outcomes after in utero transfusion in fetuses with alpha thalassemia major: a case series and review of the literature.

Kreger EM, Singer ST, Witt RG, Sweeters N, Lianoglou B, Lal A, Mackenzie TC, Vichinsky E. Kreger EM, et al. Among authors: lal a. Prenat Diagn. 2016 Dec;36(13):1242-1249. doi: 10.1002/pd.4966. Epub 2016 Dec 7. Prenat Diagn. 2016. PMID: 27862048 Review.

9

Epidemiologic and clinical characteristics of nontransfusion-dependent thalassemia in the United States.

Vichinsky E, Cohen A, Thompson AA, Giardina PJ, Lal A, Paley C, Cheng WY, McCormick N, Sasane M, Qiu Y, Kwiatkowski JL. Vichinsky E, et al. Among authors: lal a. Pediatr Blood Cancer. 2018 Jul;65(7):e27067. doi: 10.1002/pbc.27067. Epub 2018 Apr 10. Pediatr Blood Cancer. 2018. PMID: 29637688

10

Transfusion practices and complications in thalassemia.

Lal A, Wong TE, Andrews J, Balasa VV, Chung JH, Forester CM, Ikeda AK, Keel SB, Pagano MB, Puthenveetil G, Shah SJ, Yu JC, Vichinsky EP. Lal A, et al. Transfusion. 2018 Dec;58(12):2826-2835. doi: 10.1111/trf.14875. Epub 2018 Sep 27. Transfusion. 2018. PMID: 30260477 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,496 results

Search Page

Filters